Literature DB >> 20429582

The human estrogen sulfotransferase: a half-site reactive enzyme.

Meihao Sun1, Thomas S Leyh.   

Abstract

The affinity of 17beta-estradiol (E(2)) for the estrogen receptor is weakened beyond the point of physiological relevance by the transfer of the sulfuryl moiety (-SO(3)) from PAPS (3'-phosphoadenosine 5'-phosphosulfate) to the 3'-hydroxyl of E(2). The mechanism of this transfer reaction, catalyzed by estrogen sulfotransferase (EST), is investigated here in detail. The enzyme (a dimer of identical protomers) presents a clear example of half-sites reactivity--only one of the subunits of the dimer produces product during the catalytic cycle. This is the first example of half-sites reactivity in the sulfotransferase family. A burst of product, with an amplitude that corresponds to one-half of the available active sites, reveals that the mechanism is rate-limited by product release. The equilibrium constant governing interconversion of the substrate (E.PAPS.E(2)) and product (E.PAP.E(2)S) central complexes was determined and is strongly biased toward product (K(eq int) approximately 49). Slow product release allows the interconversion of the central complexes to approach equilibrium, with the result that K(eq int) becomes nearly linearly coupled to K(m) and contributes a factor of approximately 30 to the steady-state affinity of the enzyme for substrate. Typical of its family, estrogen sulfotransferase is partially k(cat)-inhibited by its acceptor substrate, E(2). This inhibition does not influence the burst kinetics and thus occurs after formation of the product central complex, a finding consistent with the slow escape of PAP from the nonreactive E.PAP.E(2) complex.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20429582      PMCID: PMC2913251          DOI: 10.1021/bi902190r

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  40 in total

Review 1.  Sulfotransferases in the bioactivation of xenobiotics.

Authors:  H Glatt
Journal:  Chem Biol Interact       Date:  2000-12-01       Impact factor: 5.192

2.  The dimerization motif of cytosolic sulfotransferases.

Authors:  E V Petrotchenko; L C Pedersen; C H Borchers; K B Tomer; M Negishi
Journal:  FEBS Lett       Date:  2001-02-09       Impact factor: 4.124

Review 3.  Chemistry and biology of heparin mimetics that bind to fibroblast growth factors.

Authors:  Hammed H A M Hassan
Journal:  Mini Rev Med Chem       Date:  2007-12       Impact factor: 3.862

4.  The specificity of the estrogen receptor of human uterus.

Authors:  R Hähnel; E Twaddle; T Ratajczak
Journal:  J Steroid Biochem       Date:  1973-01       Impact factor: 4.292

Review 5.  Sulfation through the looking glass--recent advances in sulfotransferase research for the curious.

Authors:  M W H Coughtrie
Journal:  Pharmacogenomics J       Date:  2002       Impact factor: 3.550

6.  An unusually small dimer interface is observed in all available crystal structures of cytosolic sulfotransferases.

Authors:  Brian Weitzner; Thomas Meehan; Qifang Xu; Roland L Dunbrack
Journal:  Proteins       Date:  2009-05-01

7.  Pattern and temporal sequence of sulfation of CCR5 N-terminal peptides by tyrosylprotein sulfotransferase-2: an assessment of the effects of N-terminal residues.

Authors:  Connie H Jen; Kevin L Moore; Julie A Leary
Journal:  Biochemistry       Date:  2009-06-16       Impact factor: 3.162

8.  A type I-secreted, sulfated peptide triggers XA21-mediated innate immunity.

Authors:  Sang-Won Lee; Sang-Wook Han; Malinee Sririyanum; Chang-Jin Park; Young-Su Seo; Pamela C Ronald
Journal:  Science       Date:  2009-11-06       Impact factor: 47.728

Review 9.  Pharmacogenetics of soluble sulfotransferases (SULTs).

Authors:  Hansruedi Glatt; Walter Meinl
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-11-05       Impact factor: 3.000

10.  Cysteine biosynthetic enzymes are the pieces of a metabolic energy pump.

Authors:  Jiang Wei; Qing-Xiu Tang; Olga Varlamova; Camille Roche; Reaching Lee; Thomas S Leyh
Journal:  Biochemistry       Date:  2002-07-02       Impact factor: 3.162

View more
  21 in total

1.  Analytical expressions for the homotropic binding of ligand to protein dimers and trimers.

Authors:  Scott T Lefurgy; Thomas S Leyh
Journal:  Anal Biochem       Date:  2011-12-16       Impact factor: 3.365

Review 2.  Structure, dynamics and selectivity in the sulfotransferase family.

Authors:  Thomas S Leyh; Ian Cook; Ting Wang
Journal:  Drug Metab Rev       Date:  2013-09-11       Impact factor: 4.518

3.  High accuracy in silico sulfotransferase models.

Authors:  Ian Cook; Ting Wang; Charles N Falany; Thomas S Leyh
Journal:  J Biol Chem       Date:  2013-10-15       Impact factor: 5.157

4.  Testing the sulfotransferase molecular pore hypothesis.

Authors:  Ian Cook; Ting Wang; Steven C Almo; Jungwook Kim; Charles N Falany; Thomas S Leyh
Journal:  J Biol Chem       Date:  2013-01-28       Impact factor: 5.157

5.  Isoform-specific therapeutic control of sulfonation in humans.

Authors:  Ian Cook; Ting Wang; Thomas S Leyh
Journal:  Biochem Pharmacol       Date:  2018-11-10       Impact factor: 5.858

6.  A nucleotide-gated molecular pore selects sulfotransferase substrates.

Authors:  Ian Cook; Ting Wang; Charles N Falany; Thomas S Leyh
Journal:  Biochemistry       Date:  2012-06-29       Impact factor: 3.162

7.  The NSAID allosteric site of human cytosolic sulfotransferases.

Authors:  Ting Wang; Ian Cook; Thomas S Leyh
Journal:  J Biol Chem       Date:  2017-10-16       Impact factor: 5.157

8.  The gate that governs sulfotransferase selectivity.

Authors:  Ian Cook; Ting Wang; Steven C Almo; Jungwook Kim; Charles N Falany; Thomas S Leyh
Journal:  Biochemistry       Date:  2012-12-28       Impact factor: 3.162

9.  Paradigms of sulfotransferase catalysis: the mechanism of SULT2A1.

Authors:  Ting Wang; Ian Cook; Charles N Falany; Thomas S Leyh
Journal:  J Biol Chem       Date:  2014-07-23       Impact factor: 5.157

10.  The allosteric binding sites of sulfotransferase 1A1.

Authors:  Ian Cook; Ting Wang; Charles N Falany; Thomas S Leyh
Journal:  Drug Metab Dispos       Date:  2014-12-22       Impact factor: 3.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.